Simulations Plus Inc
NASDAQ:SLP

Watchlist Manager
Simulations Plus Inc Logo
Simulations Plus Inc
NASDAQ:SLP
Watchlist
Price: 31.32 USD 4.26% Market Closed
Market Cap: 628.6m USD
Have any thoughts about
Simulations Plus Inc?
Write Note

Gross Margin
Simulations Plus Inc

61.6%
Current
77%
Average
47.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
61.6%
=
Gross Profit
43.2m
/
Revenue
70m

Gross Margin Across Competitors

Country US
Market Cap 628m USD
Gross Margin
62%
Country US
Market Cap 35B USD
Gross Margin
73%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 23.2B AUD
Gross Margin
100%
Country US
Market Cap 9B USD
Gross Margin
90%
Country JP
Market Cap 967.6B JPY
Gross Margin
58%
Country US
Market Cap 5.7B USD
Gross Margin
85%
Country US
Market Cap 5.4B USD
Gross Margin
67%
Country SE
Market Cap 53.1B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 16.4B CNY
Gross Margin
43%
No Stocks Found

Simulations Plus Inc
Glance View

Market Cap
628m USD
Industry
Health Care

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.

SLP Intrinsic Value
20.55 USD
Overvaluation 34%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
61.6%
=
Gross Profit
43.2m
/
Revenue
70m
What is the Gross Margin of Simulations Plus Inc?

Based on Simulations Plus Inc's most recent financial statements, the company has Gross Margin of 61.6%.